Fiasp Now Approved HCP Website Oct 26, 2017Oct 25, 2017 Brand: Fiasp (insulin aspart), Injection Parent Company: Novo Nordisk Drug Type: Prescription Drug Category: Endocrinology Campaign: now-approved Targeting: HCPs Patient Website: https://www.myfiasp.com/ HCP Website: https://www.fiasppro.com Homepage Homepage (Mobile)